Cargando…
The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1
Nowadays, there is a growing interest in compounds derived from plants as potential raw materials for drug development. One of the most studied compounds is beta-carotene (BC). Several clinical studies can be found investigating the cardiovascular effects of BC, however, all these results are contro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979408/ https://www.ncbi.nlm.nih.gov/pubmed/29642592 http://dx.doi.org/10.3390/ijms19041132 |
_version_ | 1783327689241788416 |
---|---|
author | Csepanyi, Evelin Czompa, Attila Szabados-Furjesi, Peter Lekli, Istvan Balla, Jozsef Balla, Gyorgy Tosaki, Arpad Bak, Istvan |
author_facet | Csepanyi, Evelin Czompa, Attila Szabados-Furjesi, Peter Lekli, Istvan Balla, Jozsef Balla, Gyorgy Tosaki, Arpad Bak, Istvan |
author_sort | Csepanyi, Evelin |
collection | PubMed |
description | Nowadays, there is a growing interest in compounds derived from plants as potential raw materials for drug development. One of the most studied compounds is beta-carotene (BC). Several clinical studies can be found investigating the cardiovascular effects of BC, however, all these results are controversial. There is an increasing body of evidence showing that besides the well-known antioxidant properties, under strong oxidative circumstances, BC could become prooxidant as well. In this study, we investigated the effects of long-term, low- and high-dose BC treatment in ischemic/reperfused (ISA/REP) hearts isolated from Zucker diabetic fatty (ZDF) rats. The animals were treated with various daily doses of BC for 4 weeks and then hearts were isolated and subjected to 30 min of global ischemia (ISA) followed by 120 min of reperfusion (REP). Blood glucose levels were measured before, after two weeks, and at the end of the treatment. In isolated hearts, the myocardial function was registered. At the end of the reperfusion period, the infarct size (IS) and heme oxygenase-1 (HO-1) expression were measured. The results showed that a low dose of BC treatment significantly improved postischemic recovery, which was reflected in a decreased IS. Interestingly, when BC was applied at high concentrations, the observed protective effects were lost. Although BC treatment increased HO-1 expression, we did not observe a better heart function and/or decreased IS in the high-dose-treated group. Glucose tolerance tests showed a concentration-independent decrease in blood glucose levels. Our results suggest that long-term, low-dose BC treatment could be effective in the treatment of type-2-diabetes and related cardiovascular diseases. |
format | Online Article Text |
id | pubmed-5979408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-59794082018-06-10 The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1 Csepanyi, Evelin Czompa, Attila Szabados-Furjesi, Peter Lekli, Istvan Balla, Jozsef Balla, Gyorgy Tosaki, Arpad Bak, Istvan Int J Mol Sci Article Nowadays, there is a growing interest in compounds derived from plants as potential raw materials for drug development. One of the most studied compounds is beta-carotene (BC). Several clinical studies can be found investigating the cardiovascular effects of BC, however, all these results are controversial. There is an increasing body of evidence showing that besides the well-known antioxidant properties, under strong oxidative circumstances, BC could become prooxidant as well. In this study, we investigated the effects of long-term, low- and high-dose BC treatment in ischemic/reperfused (ISA/REP) hearts isolated from Zucker diabetic fatty (ZDF) rats. The animals were treated with various daily doses of BC for 4 weeks and then hearts were isolated and subjected to 30 min of global ischemia (ISA) followed by 120 min of reperfusion (REP). Blood glucose levels were measured before, after two weeks, and at the end of the treatment. In isolated hearts, the myocardial function was registered. At the end of the reperfusion period, the infarct size (IS) and heme oxygenase-1 (HO-1) expression were measured. The results showed that a low dose of BC treatment significantly improved postischemic recovery, which was reflected in a decreased IS. Interestingly, when BC was applied at high concentrations, the observed protective effects were lost. Although BC treatment increased HO-1 expression, we did not observe a better heart function and/or decreased IS in the high-dose-treated group. Glucose tolerance tests showed a concentration-independent decrease in blood glucose levels. Our results suggest that long-term, low-dose BC treatment could be effective in the treatment of type-2-diabetes and related cardiovascular diseases. MDPI 2018-04-10 /pmc/articles/PMC5979408/ /pubmed/29642592 http://dx.doi.org/10.3390/ijms19041132 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Csepanyi, Evelin Czompa, Attila Szabados-Furjesi, Peter Lekli, Istvan Balla, Jozsef Balla, Gyorgy Tosaki, Arpad Bak, Istvan The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1 |
title | The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1 |
title_full | The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1 |
title_fullStr | The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1 |
title_full_unstemmed | The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1 |
title_short | The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1 |
title_sort | effects of long-term, low- and high-dose beta-carotene treatment in zucker diabetic fatty rats: the role of ho-1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979408/ https://www.ncbi.nlm.nih.gov/pubmed/29642592 http://dx.doi.org/10.3390/ijms19041132 |
work_keys_str_mv | AT csepanyievelin theeffectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT czompaattila theeffectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT szabadosfurjesipeter theeffectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT lekliistvan theeffectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT ballajozsef theeffectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT ballagyorgy theeffectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT tosakiarpad theeffectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT bakistvan theeffectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT csepanyievelin effectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT czompaattila effectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT szabadosfurjesipeter effectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT lekliistvan effectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT ballajozsef effectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT ballagyorgy effectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT tosakiarpad effectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 AT bakistvan effectsoflongtermlowandhighdosebetacarotenetreatmentinzuckerdiabeticfattyratstheroleofho1 |